Prot# GS-US-402-1852: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with Nonalcoholic Steatohepatitis (NASH)

  • Rinella, Mary Eugenia (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/15/16 → 11/15/19

Funding

  • PRA Health Sciences (Prot# GS-US-402-1852 // Prot# GS-US-402-1852)
  • Gilead Sciences, Inc (Prot# GS-US-402-1852 // Prot# GS-US-402-1852)